Home About Us Contact Us

 

Table of Content - Volume 13 Issue 2 - February 2020


 

Correlation of homocysteine and lipid profile parameters with ischemic heart disease

 

Shilpa Shaunak Sule1*, N C Edul2, R S Wadia3

 

1Assistant Professor in Department of Medicine, Bharati Vidyapeeth (Deemed to be University)Medical College . Pune 411043

2Consulting Physician , 3Consulting Physician and Neurologist Professor Emeritus of Neurology Ruby Hall Clinic Pune , Maharashtra, INDIA.

Email: docshilpa84@gmail.com

 

REFERENCES

  1. Yadav AS, Bhagwat VR, Rathod MI. Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease. Ind J Clin Biochem 2006; 21(1):106-10.
  2. Narang AP, Verma I, Kaur S, Narang A. Homocysteine- Risk factor for ischaemic stroke? Ind J Physiol Pharmacol 2009; 53(1):34-8.
  3. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41:340-2.
  4. Still RA, McDowell LF. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol 1998; 51:183-8.
  5. Malinow MR, Boston AG, Krauss RM. Homocysteine, diet and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99:178-82.
  6. Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009;583(8):1215-25.
  7. Watanabe M, Osada J, Aratani Y, et al. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A. 1995;92(5):1585–9.
  8. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem. 2004;279(51):52961–9.
  9. Wang H, Jiang X, Yang F, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood. 2003;101(10):3901–7.
  10. Mikael LG, Wang XL, Wu Q, Jiang H, Maclean KN, Rozen R. Hyperhomocysteinemia is associated with hypertriglyceridemia in mice with methylenetetrahydrofolate reductase deficiency. Mol Genet Metab. 2009;98(1–2):187–94.
  11. Frauscher G, Karnaukhova E, Muehl A, Hoeger H, Lubec B. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage? Life Sci. 1995;57(8):813–7.
  12. Wasilewska A, Narkiewicz M, et al. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis? Med Sci Monit 2003; 9:147-51.
  13. Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol. 2013;61(4):289–94.
  14. de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005;19(1):42–6.